US Bancorp DE reduced its holdings in shares of Genpact Limited (NYSE:G – Free Report) by 18.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,838 shares of the business services provider’s stock after selling 2,380 shares during the period. US Bancorp DE’s holdings in Genpact were worth $425,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Janney Montgomery Scott LLC acquired a new stake in shares of Genpact in the 1st quarter valued at about $703,000. Empowered Funds LLC acquired a new position in Genpact during the 1st quarter valued at about $1,937,000. Concurrent Investment Advisors LLC boosted its stake in Genpact by 25.5% during the 1st quarter. Concurrent Investment Advisors LLC now owns 23,352 shares of the business services provider’s stock valued at $769,000 after purchasing an additional 4,748 shares during the last quarter. Headlands Technologies LLC boosted its stake in Genpact by 2,366.8% during the 1st quarter. Headlands Technologies LLC now owns 5,057 shares of the business services provider’s stock valued at $167,000 after purchasing an additional 4,852 shares during the last quarter. Finally, QRG Capital Management Inc. boosted its stake in Genpact by 6.5% during the 1st quarter. QRG Capital Management Inc. now owns 58,432 shares of the business services provider’s stock valued at $1,925,000 after purchasing an additional 3,589 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research firms have commented on G. Jefferies Financial Group lifted their target price on shares of Genpact from $35.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 9th. Needham & Company LLC lifted their target price on shares of Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a research report on Monday. Robert W. Baird lifted their price target on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday. JPMorgan Chase & Co. lifted their price target on shares of Genpact from $35.00 to $43.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, BMO Capital Markets lifted their price target on shares of Genpact from $38.00 to $42.00 and gave the stock a “market perform” rating in a report on Monday, August 12th. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $42.33.
Genpact Stock Performance
NYSE G opened at $46.66 on Tuesday. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $47.98. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.89 and a current ratio of 1.89. The company has a market capitalization of $8.31 billion, a P/E ratio of 12.82, a P/E/G ratio of 1.92 and a beta of 1.13. The company has a fifty day moving average of $39.18 and a 200-day moving average of $35.68.
Genpact Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be given a $0.1525 dividend. This represents a $0.61 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date is Monday, December 9th. Genpact’s payout ratio is presently 16.76%.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More
- Five stocks we like better than Genpact
- How to Most Effectively Use the MarketBeat Earnings Screener
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- Bank Stocks – Best Bank Stocks to Invest In
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- What is a Bond Market Holiday? How to Invest and Trade
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.